Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion type Assertion NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_head.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion description "[This finding, together with earlier work, strongly suggests that a major form of negative feedback inhibition of PI3K results from activated growth signalling via mammalian target of rapamycin (mTOR) and the p70 S6 kinase (S6K) - a pathway that could have consequences for the development of type 2 diabetes and tuberous sclerosis complex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_provenance.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion evidence source_evidence_literature NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_provenance.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion SIO_000772 15653324 NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_provenance.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion wasDerivedFrom befree-20150227 NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_provenance.
- NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_assertion wasGeneratedBy ECO_0000203 NP958724.RAdQKRHS3i1tmm44p76S92tCJpqM2cDbDhWMJ603PGIzA130_provenance.